Immunitybio
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $32,061 | $26,425 | $16,517 | $7,552 |
Gross Profit | 27,933 | 26,289 | 16,459 | 7,552 |
EBITDA | -35,774 | -59,541 | -97,206 | -40,120 |
EBIT | -39,725 | -63,421 | -101,035 | -44,274 |
Net Income | -67,253 | -92,555 | -129,646 | -59,162 |
Net Change In Cash | 32,061 | 26,425 | 16,517 | 7,552 |
Free Cash Flow | -68,907 | -80,827 | -87,026 | -87,255 |
Cash | 60,241 | 137,658 | 60,660 | 143,428 |
Basic Shares | 946,601 | 888,216 | 853,162 | 734,542 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $14,745 | $622 | $240 | $934 |
Gross Profit | 14,745 | 622 | 240 | 934 |
EBITDA | -264,433 | -478,663 | -351,881 | -320,752 |
EBIT | -281,987 | -497,175 | -370,141 | -334,990 |
Net Income | -413,564 | -583,196 | -416,567 | -346,790 |
Net Change In Cash | 14,745 | 622 | 240 | 934 |
Cost of Revenue | -76,599 | 146,138 | ||
Free Cash Flow | -398,124 | -397,341 | -415,671 | -307,982 |
Cash | 143,428 | 265,453 | 104,641 | 181,101 |
Basic Shares | 700,443 | 508,636 | 399,900 | 389,234 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.07 |
2025-06-30 | -$0.10 |
2025-03-31 | -$0.15 |
